| 发明名称 |
Oncogene fusion protein peptide vaccines |
| 摘要 |
Fusion-point spanning peptides, for example BCR-ABL fusion breakpoint peptides associated with chronic myelogenous leukemia (CML), bind major histompatibility complex molecules, such as HLA class I molecules, and induce cytotoxic T cell proliferation. The breakpoint peptides can be used as vaccines. |
| 申请公布号 |
AU5855096(A) |
申请公布日期 |
1996.11.29 |
| 申请号 |
AU19960058550 |
申请日期 |
1996.05.08 |
| 申请人 |
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH;CYTEL CORPORATION |
发明人 |
DAVID A SCHEINBERG;ALESSANDRO SETTE;MONICA BOCCHIA |
| 分类号 |
A61K39/00;A61P35/00;C07K14/47;C07K14/705;C07K14/74;C07K14/82;C12N15/62;G01N33/569;G01N33/574;G01N33/68 |
主分类号 |
A61K39/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
